Logo

Cellular Genomics to Use Affy Chips for Kinase Drug Discovery

Oct 09, 2003

NEW YORK, Oct. 9 (GenomeWeb News) - Drug maker Cellular Genomics will use Affymetrix's GeneChips together with its own Analog Sensitive Kinase Allele technology to develop assays for kinase drug discovery, the companies said today.

The firms also said the collaboration, which is the first of its kind for Affy's DNA chips, will help researchers determine "all the changes in cellular gene expression resulting from exquisitely specific small molecule-mediated human kinase target inhibition."


Cellular Genomics ASKA technology relies on small molecule analog inhibitors that inhibit genetically modified kinases.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.